Dexmedetomidine: Increased risk of mortality in intensive care unit (ICU) patients ≤65 years

Table of contents

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Medicine name
Dexdor
Active substance
dexmedetomidine hydrochloride
Therapeutic area (MeSH)
Conscious Sedation
Procedure number
EMEA/H/C/002268/II/0035
Regulatory outcome
Maintenance
DHPC type
Safety signal
Human ATC code
N05CM18
Dissemination date
16/06/2022

How useful was this page?

Add your rating